WVE · Wave Life Sciences Ltd.
$5.41
+0.21 (+4.04%)
At close · Aug 14
Market Cap
$1.07B
Shares
197.05M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$5.41
Open$5.16
Day$5.14–5.42
52W close$5.05–21.31
Avg vol 30d2.8M
Short int16.4M · 8.3% float · 7.5d
Short vol36%
Last earningsJul 30, 2026
DataJan 2020–Aug 2026
Filing10-Q · Jul 30
Up next
Next earnings call
Oct 25, 2026
Est · unconfirmed
· in 10 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Jul 30, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Strong Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 14.3 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−43%
below
Price vs 50-day avg
−8%
below
RSI (14)
42
neutral
MACD trend
Negative
52-week position
2%
near low
Momentum
relative strength
1-month return
−7%
trailing
6-month return
−60%
trailing
YTD return
−68%
this year
Relative strength
−74%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $6 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +49 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.32% of float · ▼ -2.7% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
239 holders — near 3-yr high, broad support
Squeeze score
59
elevated · 0–100
Fundamentals
Revenue growth
+149%
Y/Y
EPS growth
−73%
Y/Y
Free cash flow
$-188.2M
Balance sheet
$602.1M
net cash
Quant / Vol
risk profile
Volatility
169%
annualized · 1-yr
Max drawdown
−76%
past year
ATR
6.4%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Strong Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−43%
Bearish
Price vs 50-day avg
−8%
Bearish
RSI (14)
42
Neutral
MACD trend
Negative
Bearish
52-week position
2%
Bearish
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $6 › 200d $10 — 200d above 50d
Institutional flow
Accumulating
+1% holders QoQ · +49 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
8.32% of float · ▼ -2.7% MoM · 7.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Multi-yr high
239 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $5
Now $5 · 2%
Range high $21
vs 200-day avg -43%
vs 50-day avg -8%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
WVE
this stock
Wave Life Sciences Ltd.
|
$1.07B | -68.2% | +149.4% | — | 8.3% |
|
ONC
BeOne Medicines Ltd.
|
$513.62B | +14.4% | +22179.2% | 789.7 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$128.19B | +11.6% | +46.2% | 29.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$82.72B | +4.1% | +20.8% | 19.9 | 3.3% |
|
ARGX
Argenx SE
|
$52.94B | +1.2% | — | — | 2.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| WVE | -11.3% | -7.0% | -59.9% | -1.8% | -68.2% |
| SPY | +0.4% | +4.5% | +13.8% | +3.9% | +13.9% |
| vs SPY | -11.7% | -11.5% | -73.7% | -5.7% | -82.0% |
Key facts
CIK
1631574
CUSIP
Y95308105
13F (30d)
234 filings
230 filers
Visit website
Investor relations